Torrent Pharmaceuticals Limited
Torrent Pharmaceuticals Limited engages in the research, development, manufacturing, marketing, and distribution of branded and generic pharmaceutical formulations in India, the United States, Brazil, Germany, and internationally. The company offers products in various therapeutic areas, including anti-diabetic, anti-microbial, cardiovascular, urology, gynecology, oncology, gastro-intestinal, nep… Read more
Torrent Pharmaceuticals Limited (TORNTPHARM) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: 0.123x
Based on the latest financial reports, Torrent Pharmaceuticals Limited (TORNTPHARM) has a cash flow conversion efficiency ratio of 0.123x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₹10.38 Billion) by net assets (₹84.49 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Torrent Pharmaceuticals Limited - Cash Flow Conversion Efficiency Trend (2005–2025)
This chart illustrates how Torrent Pharmaceuticals Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Torrent Pharmaceuticals Limited Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Torrent Pharmaceuticals Limited ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
AVIC Jonhon Optronic Technology Co Ltd
SHE:002179
|
-0.036x |
|
CAR Group Ltd
AU:CAR
|
0.079x |
|
Wingstop Inc
NASDAQ:WING
|
-0.091x |
|
Avantor Inc
NYSE:AVTR
|
0.027x |
|
PNM Resources Inc
F:98P
|
0.081x |
|
PIRAEUS FIN.HOL. EO 093
F:BKP
|
N/A |
|
MYTILINEOS SA NAM.EO 097
F:MYH
|
N/A |
|
Bharat Forge Limited
NSE:BHARATFORG
|
0.107x |
Annual Cash Flow Conversion Efficiency for Torrent Pharmaceuticals Limited (2005–2025)
The table below shows the annual cash flow conversion efficiency of Torrent Pharmaceuticals Limited from 2005 to 2025.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-03-31 | ₹75.91 Billion | ₹25.85 Billion | 0.341x | -28.51% |
| 2024-03-31 | ₹68.56 Billion | ₹32.66 Billion | 0.476x | +24.69% |
| 2023-03-31 | ₹61.98 Billion | ₹23.68 Billion | 0.382x | +26.14% |
| 2022-03-31 | ₹59.53 Billion | ₹18.03 Billion | 0.303x | -12.07% |
| 2021-03-31 | ₹58.37 Billion | ₹20.11 Billion | 0.344x | +19.37% |
| 2020-03-31 | ₹48.23 Billion | ₹13.92 Billion | 0.289x | -24.18% |
| 2019-03-31 | ₹47.24 Billion | ₹17.98 Billion | 0.381x | +96.76% |
| 2018-03-31 | ₹46.23 Billion | ₹8.94 Billion | 0.193x | -16.90% |
| 2017-03-31 | ₹43.51 Billion | ₹10.13 Billion | 0.233x | -70.92% |
| 2016-03-31 | ₹33.89 Billion | ₹27.13 Billion | 0.800x | +146.11% |
| 2015-03-31 | ₹24.91 Billion | ₹8.10 Billion | 0.325x | +3.25% |
| 2014-03-31 | ₹19.03 Billion | ₹5.99 Billion | 0.315x | +191.92% |
| 2013-03-31 | ₹14.22 Billion | ₹1.53 Billion | 0.108x | -74.53% |
| 2012-03-31 | ₹11.97 Billion | ₹5.07 Billion | 0.424x | +9.98% |
| 2011-03-31 | ₹10.24 Billion | ₹3.95 Billion | 0.385x | +11.56% |
| 2010-03-31 | ₹8.31 Billion | ₹2.87 Billion | 0.345x | -12.83% |
| 2009-03-31 | ₹6.51 Billion | ₹2.58 Billion | 0.396x | -16.47% |
| 2008-03-31 | ₹5.10 Billion | ₹2.42 Billion | 0.474x | +164.43% |
| 2007-03-31 | ₹4.10 Billion | ₹735.97 Million | 0.179x | +81.59% |
| 2006-03-31 | ₹3.48 Billion | ₹343.63 Million | 0.099x | +23.72% |
| 2005-03-31 | ₹3.16 Billion | ₹251.96 Million | 0.080x | -- |